XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments 
Precipio Announces Q3-2020 Shareholder Update Call
Conference Call to be held on Thursday, November 19th, 2020 at 5:00 PM EST NEW HAVEN, Conn., Nov. 11, 2020...
BioDelivery Sciences to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company...
Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy
Registry to Enable Prospective Safety Study “DISCOVER-HCM” to Track Long-Term Safety and Effectiveness of Mavacamten in Patients with Symptomatic, Obstructive...
IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films
SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company,...
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in...
Better Choice Company to Host Third Quarter 2020 Financial Results Call on November 18 at 8:30 a.m. ET
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company,...
Avadel Pharmaceuticals to Present at Upcoming November 2020 Investor Conferences
DUBLIN, Ireland, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting
-Preclinical data highlight Jounce’s approach to identify potential predictive and pharmacodynamic biomarkers to identify patients who may benefit from JTX-8064-...
Receptor Life Sciences Names Gregory Mayes to Board of Directors
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences (Receptor) today announced the appointment of Gregory T. Mayes, J.D....
scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
ORYZON to Present Further Positive Efficacy Data From Iadademstat ALICE Phase IIa Trial at the 62nd Congress of the American Society of Hematology
Will also present at Jefferies 2020 Virtual London Healthcare Conference CEO to participate in a Borderline Personality Disorder Day panel...
CymaBay Therapeutics to Present at Upcoming Investor Conferences
NEWARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sarcoma at CTOS 2020 Virtual Annual Meeting
Interim Phase 1 data in patients with relapsed/refractory Ewing sarcoma treated at the recommended Phase 2 dose of TK216 demonstrated...
Kronos Bio Announces Participation in the Jefferies Virtual London Healthcare Conference
SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated...
Kymera Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
WATERTOWN, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and...
Spectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood Purification
Operating the SAMI viewed as both simple and safe by the nurses Successful remote deployment of SAMI with only 3...